Journal of Taibah University Medical Sciences · 2026
Comparative analysis of excessive daytime sleepiness and sleep apnea symptoms in renal transplant recipients and a historical dialysis cohort.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alharbi Turki, Alahmadi Salman, Almejaish Turki, Alburodi Amer, Alsaif Mohammed, Albader Mohammed, Altheaby Abdulrahman, Al-Jahdali Ziad, Rajendram Rajkumar, Al-Jahdali Hamdan
Аннотация
OBJECTIVES: Sleep disorders are prevalent in end-stage renal failure (ESRF) patients on dialysis. Renal transplantation may enhance the quality of sleep but comparative data are limited. The aim of our study was to assess the prevalence and factors linked to self-reported obstructive sleep apnea (OSA) and excessive daytime sleepiness (EDS) in kidney transplant recipients compared with dialysis patients.
METHODS: This cross-sectional study analyzed 159 renal transplant recipients using the STOP-BANG questionnaire, Berlin Questionnaire, and Epworth Sleepiness Scale. These results were compared to those for a historical cohort of 227 dialysis patients. Multinomial logistic regression models adjusted for demographic and clinical confounders were used to explore associations.
RESULTS: In the combined cohort, 27.5% reported EDS (44.1% in dialysis vs. 3.8% in transplant patients, P < 0.001) and 30.6% reported OSA risk (41.9% in dialysis vs. 14.5% in transplant patients, P < 0.001). After adjusting for age, sex, body mass index, neck size, smoking, coffee intake, and comorbidities, renal transplantation was significantly associated with lower adjusted odds of EDS (odds ratio (OR): 0.014), OSA (OR: 0.422), and co-occurrence (OR: 0.092). No polysomnography data were available.
CONCLUSION: Renal transplant patients reported fewer symptoms of EDS and OSA risk compared with dialysis patients, indicating potential benefits of transplantation beyond renal function.
METHODS: This cross-sectional study analyzed 159 renal transplant recipients using the STOP-BANG questionnaire, Berlin Questionnaire, and Epworth Sleepiness Scale. These results were compared to those for a historical cohort of 227 dialysis patients. Multinomial logistic regression models adjusted for demographic and clinical confounders were used to explore associations.
RESULTS: In the combined cohort, 27.5% reported EDS (44.1% in dialysis vs. 3.8% in transplant patients, P < 0.001) and 30.6% reported OSA risk (41.9% in dialysis vs. 14.5% in transplant patients, P < 0.001). After adjusting for age, sex, body mass index, neck size, smoking, coffee intake, and comorbidities, renal transplantation was significantly associated with lower adjusted odds of EDS (odds ratio (OR): 0.014), OSA (OR: 0.422), and co-occurrence (OR: 0.092). No polysomnography data were available.
CONCLUSION: Renal transplant patients reported fewer symptoms of EDS and OSA risk compared with dialysis patients, indicating potential benefits of transplantation beyond renal function.